Background Insulin resistance and hypertension are common co-existing conditions. Antihypertensive agents have differing effects on insulin sensitivity (SI). We studied 11 mildly hypertensive insulin-resistant type 2 diabetic patients to observe any changes in SI, glucose effectiveness (SG), serum total cholesterol, serum triglycerides and blood pressure (BP) with the introduction of the angiotensin II inhibitor, losartan.
Methods To assess SI and SG, we used the frequently sampled, intravenous glucose tolerance test with minimal model analysis prior to and after three months treatment with losartan potassium 50—100 mg daily. BP was assessed using a Space Labs 24-hour BP recording device before, during and after treatment with losartan.
Results There were no significant differences in SI and SG pre-and post-treatment, however, there was a non-significant reduction in mean BP, total cholesterol and triglyceride concentrations.
Conclusion There were no adverse effects of losartan on SI or SG. The lower but non-significant serum total cholesterol and triglyceride concentrations warrant further study.
Giugliano D. , Acampora R., Marfella R. et al. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependant diabetes mellitus and hypertension. A randomised, controlled trial. Ann Intern Med1997;126:955-9.
2.
Jasik M., Kasperska-Dworak A., Czyzyk A.Effect of nifedipine, captopril and prazosin on secretory function of pancreatic beta-cells in hypertensive patients with type-2 diabetes and in hypertensive non-diabetics. Diab Res Clin Pract1996;33:59-66.
3.
Iimura O., Shimamoto K., Matsuda K. et al. Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives. Am J Hypertension1995;8:353-7.
4.
Laasko M., Karjalainen L., Lempiainen-Kuosa P.Effects of losartan on insulin sensitivity in hypertensive subjects . Hypertension1996;28:392-6.
5.
Bergman RN, Ider YZ, Bowden CR, Cobelli C.Quantitative estimation of insulin sensitivity. Am J Physiol1979;236:E667-677.
6.
UK Prospective Diabetes Study Group.Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ1998;317:703-13.
7.
Boden G., Chen X., Urbain JLEvidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused cyclic changes in hepatic glucose production. Diabetes1996;45:1044-50.
8.
Lee A., Ader M., Bray G., Bergman RNDiurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects. Diabetes1992;41:750-9.
